Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Yonina Bykov
Observed name:
Y. Bykov
Institution:
Icahn School of Medicine at Mount Sinai
Observed institutions:
Memorial Sloan Kettering Cancer Center,
Swim Across America,
Parker Institute for Cancer Immunotherapy,
Icahn School of Medicine at Mount Sinai
ORCID:
0000-0002-0834-0953
Observed ORCID:
0000-0002-0834-0953
OpenAlex ID:
A5070502758
Ovarian cancer mutational processes drive site-specific immune evasion
2022
·
Ignacio Vázquez-García
, Florian Uhlitz
, et al.
·
Nature
·
364
PDF
Unraveling tumor–immune heterogeneity in advanced ovarian cancer uncovers immunogenic effect of chemotherapy
2020
·
Alejandro Jiménez-Sánchez
, Paulina Cybulska
, et al.
·
Nature Genetics
·
263
PDF
Tim-4+ cavity-resident macrophages impair anti-tumor CD8+ T cell immunity
2021
·
Andrew Chow
, Sara Schad
, et al.
·
Cancer Cell
·
207
PDF
Identification of recurrent FHL2-GLI2 oncogenic fusion in sclerosing stromal tumors of the ovary
2020
·
Sarah H. Kim
, Arnaud Da Cruz Paula
, et al.
·
Nature Communications
·
65
PDF
Increased p53 expression induced by APR-246 reprograms tumor-associated macrophages to augment immune checkpoint blockade
2022
·
Arnab Ghosh
, Judith Michels
, et al.
·
Journal of Clinical Investigation
·
34
PDF
Interferon response and epigenetic modulation by SMARCA4 mutations drive ovarian tumor immunogenicity
2024
·
Melica Nourmoussavi Brodeur
, Higinio Dopeso
, et al.
·
Science Advances
·
26
PDF
Preparation of single cells from tumors for single-cell RNA sequencing
2019
·
Yonina Bykov
, Sarah H. Kim
, et al.
·
Methods in enzymology on CD-ROM/Methods in enzymology
·
15
Outcome of SARS-CoV-2 reinfection depends on genetic background in female mice
2024
·
Gagandeep Singh
, Juan García-Bernalt Diego
, et al.
·
Nature Communications
·
10
PDF
T cell epitope mapping reveals immunodominance of evolutionarily conserved regions within SARS-CoV-2 proteome
2025
·
Cansu Cimen Bozkus
, Matthew Brown
, et al.
·
iScience
·
9
PDF
Avian Paramyxovirus 4 Antitumor Activity Leads to Complete Remissions and Long-term Protective Memory in Preclinical Melanoma and Colon Carcinoma Models
2022
·
Aryana Javaheri
, Yonina Bykov
, et al.
·
Cancer Research Communications
·
9
Phase I/II study to evaluate systemic durvalumab + intraperitoneal (IP) ONCOS-102 in patients with peritoneal disease who have epithelial ovarian (OC) or metastatic colorectal cancer (CRC): Interim phase I clinical and translational results.
2020
·
Dmitriy Zamarin
, Kunle Odunsi
, et al.
·
Journal of Clinical Oncology
·
8
Virus, Vessel, Victory: A Novel Approach to Tumor Killing
2018
·
Yonina Bykov
, Dmitriy Zamarin
·
Clinical Cancer Research
·
6
Immune responses elicited by ssRNA(-) oncolytic viruses in the host and in the tumor microenvironment
2023
·
Yonina Bykov
, Gloria Dawodu
, et al.
·
Journal of Cancer Metastasis and Treatment
·
5
PDF
A pilot study of nivolumab in combination with front-line neoadjuvant dose-dense paclitaxel and carboplatin chemotherapy in patients with high-grade serous ovarian cancer
2020
·
C.F. Friedman
, A. Snyder
, et al.
·
Gynecologic Oncology
·
4
Infectious bursal disease virus (IBDV) as a novel oncolytic virotherapy in glioblastoma
2025
·
Vicent Tur-Planells
, Yonina Bykov
, et al.
·
Journal for ImmunoTherapy of Cancer
·
2
PDF
Abstract 2553: Immune and malignant cell phenotypes of ovarian cancer are determined by distinct mutational processes
2022
·
Ignacio Vázquez-García
, Florian Uhlitz
, et al.
·
Cancer Research
·
2
Lymphangiogenesis driven by VEGF-C reshapes tumor immune landscape and enables tumor eradication by viral immunotherapy in mouse melanoma models
2026
·
Ruben Fernandez-Rodriguez
, Sara Cuadrado-Castano
, et al.
·
Cell Reports
·
1
In situ APMV-4 vaccination primes systemic response to subtherapeutic dosing of aCTLA-4 in colorectal carcinoma
2026
·
Yonina Bykov
, Natalia Alonso Moreda
, et al.
·
Journal for ImmunoTherapy of Cancer
PDF
Cardiac glycosides activate non-canonical STAT1 signaling to reprogram antigen-presenting cells 2310011
2026
·
Sunnie Yoh
, Christian Beusch
, et al.
·
The Journal of Immunology
Abstract 4365: Pre-existing immunity boosts therapeutic efficacy of oncolytic influenza a virus in the presence and absence of neutralizing antibodies
2026
·
Gloria Dawodu
, Soner Yildiz
, et al.
·
Cancer Research
Abstract 2904: Infectious bursal disease virus (IBDV) as a novel virotherapy for stimulating innate and adaptive immune responses in different cancer models
2026
·
Vicent Tur Planells
, Yonina Bykov
, et al.
·
Cancer Research
632 In situ APMV-4 vaccination achieves systemic tumor clearance and long-term antitumor immunity, priming response to sub-therapeutic dosing of aCTLA-4 in colorectal carcinoma
2025
·
Yonina Bykov
, Naseem Sadek
, et al.
·
Journal for ImmunoTherapy of Cancer
PDF
892 Pre-existing immunity boosts therapeutic efficacy of oncolytic influenza a virus in the presence and absence of neutralizing antibodies
2025
·
Gloria Dawodu
, Adolfo Garcia-Sastre
, et al.
·
Journal for ImmunoTherapy of Cancer
PDF
766 In situ rAPMV-4 tumor vaccination achieves complete responses, long-term antitumor immunity with systemic tumor clearance, priming response to sub-therapeutic dosing of aCTLA-4 in colorectal carcinoma
2024
·
Yonina Bykov
, Adolfo Garcia-Sastre
, et al.
·
Journal for ImmunoTherapy of Cancer
1335 Infectious Bursal Disease Virus (IBDV) as a novel virotherapy for remodeling the tumor microenvironment (TME) and stimulating innate and adaptive immune responses in different murine cancer models
2024
·
Vicent Tur Planells
, Yonina Bykov
, et al.
·
Journal for ImmunoTherapy of Cancer
Show more works
View as search
Works count:
38
Citation count:
1,030
H-index:
9
I10-index:
8
Year
Topic
Type